Short-course Radiotherapy Combined With Retlirafusp Alfa and CAPOX Chemotherapy as Neoadjuvant Therapy for Locally Advanced Rectal Cancer: A Prospective, Single-arm, Phase II Clinical Study

NCT07663071 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer Patients

Interventions

DRUG: Short-course radiotherapy combined with Retlirafusp alfa and CAPOX chemotherapy

Sponsor

Harbin Medical University